Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
Clinical trial NCT07013279 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07013279
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2025-12-31
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.